Positions

Principal Investigator On

  • Private Grant  awarded by INCYTE CORPORATION 2021 - 2026
  • Private Grant  awarded by GENMAB 2021 - 2026
  • Private Grant  awarded by GENMAB 2021 - 2026
  • Private Grant  awarded by Genentech 2020 - 2025
  • Private Grant  awarded by TG THERAPEUTICS 2020 - 2024
  • Private Grant  awarded by Gilead Sciences ^ 2021 - 2024

    • Investigator On

  • Private Grant  awarded by FATE THERAPEUTICS, INC. 2021 - 2026
  • UAB 2078: A Multi-Center, Open-Label, Phase 1/2 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-101 Monotherapy and AB-101 Plus Rituximab in Patients with Relapsed/Refractory Non–Hodgkin Lymphoma of B-Cell Origin  awarded by ARTIVA BIOTHERAPEUTICS INC 2021 - 2026
  • Private Grant  awarded by JUNO THERAPEUTICS 2021 - 2026
  • UAB 1923: A Phase 2 Front-Line PET/CT-2 Response-Adapted Brentuximab Vedotin and Nivolumab Incorporated and Radiation-Free Management of Early Stage Classical Hodgkin Lymphoma (cHL) study  awarded by City of Hope 2021 - 2026
  • Private Grant  awarded by INCYTE CORPORATION 2020 - 2025
  • SWOG Purchase Services Agreement  awarded by Oregon Health & Science University 2020 - 2025
  • Private Grant  awarded by JUNO THERAPEUTICS 2019 - 2024
  • Private Grant  awarded by TG THERAPEUTICS 2019 - 2024
  • Private Grant  awarded by TG THERAPEUTICS 2021 - 2024
  • Private Grant  awarded by INNATE PHARMA 2021 - 2024
  • A Multicenter Retrospective Analysis of Treatment Patterns and Outcomes in Patients with Rare T-Cell Lymphoma Subtypes  awarded by NHS GREATER GLASGOW AND CLYDE 2021 - 2024
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2021 - 2024
  • Private Grant  awarded by Genentech 2019 - 2024
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2019 - 2024
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2020 - 2023
  • Private Grant  awarded by Genentech 2018 - 2023
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2020 - 2023
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2020 - 2023
  • A Multicenter Retrospective Analysis of Treatment Patterns and Outcomes in Patients with Rare T-Cell Lymphoma Subtypes  awarded by Memorial Sloan-Kettering Cancer Center 2021 - 2023
  • Private Grant  awarded by JUNO THERAPEUTICS 2020 - 2023
  • Private Grant  awarded by ASTEX PHARMACEUTICALS 2018 - 2023
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2018 - 2022
  • Private Grant  awarded by MILLENNIUM PHARMACEUTICALS, INC. 2020 - 2022
  • Private Grant  awarded by AFFIMED GMBH 2020 - 2022
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2022
  • Private Grant  awarded by Genentech 2019 - 2022
  • Private Grant  awarded by INNATE PHARMA 2020 - 2022
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2022
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2015 - 2022
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2015 - 2021
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014 - 2021
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2016 - 2021
  • Private Grant  awarded by Gilead Sciences ^ 2018 - 2020

    • Education And Training

  • Bachelor of Medicine & Surgery (MBBS), Maharashtra University of Health Sciences 2012

    • Full Name

  • Mayur Narkhede